comparemela.com

Latest Breaking News On - Krishnanh harshan - Page 1 : comparemela.com

Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

The University of Hyderabad (UoH) and the Centre for Cellular Molecular Biology (CCMB) in collaboration with VINS Bioproducts Limited, a leading immunological company based in Hyderabad, announced the successful completion of the Phase-two clinical trials of VINCOV-19, India s first antidote and a cure against SARS-CoV-2 virus.

Andhra pradeshVinayk nandicooriAatmanirbhar bharatKrishnanh harshanNooruddin khanCentre for cellular molecular biologySchool of life sciencesUniversity of hyderabad uoUniversity of hyderabadDepartment of animal biologyCellular molecular biologyAssociate professorAnimal biologyLife sciencesSiddharth dagaChief executive officer

Welcome To IANS Live - LatestNews - Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

VINCOV-19 is now ready for market authorisation and for simultaneous phase-three clinical trials, UoH said on Tuesday.Phas

Andhra pradeshVinayk nandicooriAatmanirbhar bharatKrishnanh harshanNooruddin khanCentre for cellular molecular biologySchool of life sciencesUniversity of hyderabad uoUniversity of hyderabadDepartment of animal biologyCellular molecular biologyAssociate professorAnimal biologyLife sciencesSiddharth dagaChief executive officer

Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

The University of Hyderabad (UoH) and the Centre for Cellular Molecular Biology (CCMB) in collaboration with VINS Bioproducts Limited, a leading immunological company based in Hyderabad, announced the successful completion of the Phase-two .

Andhra pradeshVinayk nandicooriAatmanirbhar bharatKrishnanh harshanNooruddin khanCentre for cellular molecular biologySchool of life sciencesUniversity of hyderabad uoUniversity of hyderabadDepartment of animal biologyCellular molecular biologyAssociate professorAnimal biologyLife sciencesSiddharth dagaChief executive officer

Welcome To IANS Live - SCIENCE-AND-TECHNOLOGY - Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

VINCOV-19 is now ready for market authorisation and for simultaneous phase-three clinical trials, UoH said on Tuesday.Phas

Andhra pradeshVinayk nandicooriAatmanirbhar bharatKrishnanh harshanNooruddin khanCentre for cellular molecular biologySchool of life sciencesUniversity of hyderabad uoUniversity of hyderabadDepartment of animal biologyCellular molecular biologyAssociate professorAnimal biologyLife sciencesSiddharth dagaChief executive officer

Welcome To IANS Live - NATION - Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

VINCOV-19 is now ready for market authorisation and for simultaneous phase-three clinical trials, UoH said on Tuesday.Phas

Andhra pradeshVinayk nandicooriAatmanirbhar bharatKrishnanh harshanNooruddin khanCentre for cellular molecular biologySchool of life sciencesUniversity of hyderabad uoUniversity of hyderabadDepartment of animal biologyCellular molecular biologyAssociate professorAnimal biologyLife sciencesSiddharth dagaChief executive officer

vimarsana © 2020. All Rights Reserved.